Clinical Articles
Copyright ©The Author(s) 1996.
World J Gastroenterol. Sep 15, 1996; 2(3): 158-160
Published online Sep 15, 1996. doi: 10.3748/wjg.v2.i3.158
Table 1 General conditions and methods of treatment
SubjectsGF groupBS group
Number5056
Clinical stage; cases (%)
I3 (6.0)4 (7.1)
II42 (84.0)46 (82.2)
III5 (10.0)6 (10.7)
Pathologic type; cases (%)
Massive38 (76.0)43 (76.8)
Multinodular12 (24.0)13 (23.2)
Proximal angioembolusGF powdersBS powders
Total number of treatments203151
Mean number of treatments4.062.7
Mean intermission between treatments (mo)3-66-12
Table 2 Survival rates and survival times for patients in the two groups (Life-table method: U-test
GroupnSurvival rates (%)
Mean survival time (mo)
6 m12 m24 m36 m
BS5692.981.944.933.619.8
GF5080.0a48.9b31.1c16.0d15.7